Healthtech startup CURAPOD has raised ₹20 crore (around $2.2 million) in a pre-Series A funding round led by V3 Ventures, 3i Partners, and Ideaspring Capital. The company is also backed by Litemed.
Funding To Accelerate R&D And Market Expansion
CURAPOD plans to deploy the fresh capital toward accelerating research and development, enhancing its wearable device and companion mobile application, scaling manufacturing capacity, and strengthening go-to-market strategies. The startup also intends to expand its direct-to-consumer presence while building partnerships with gyms, physiotherapy centres, and sports medicine networks.
Wearable Technology For Non-Invasive Pain Management
Founded in 2022 by Sri Velliyur and Surya Maguluri, CURAPOD develops wearable, non-invasive pain management devices focused on musculoskeletal disorders. The company’s technology is based on photobiomodulation therapy, designed to address conditions such as back pain, neck pain, knee pain, joint disorders, muscle stiffness, and sports-related injuries.
The device is FDA-registered and supports treatment across more than 30 musculoskeletal conditions, offering a drug-free alternative to conventional pain management solutions.
Clinician-Led Adoption And Expansion Strategy
CURAPOD follows a clinician-led adoption model to drive trust and product adoption across healthcare networks. As musculoskeletal disorders become increasingly common due to sedentary lifestyles and sports-related injuries, the company aims to expand its footprint across India while strengthening distribution and healthcare partnerships.
With the new funding, CURAPOD plans to scale product innovation and improve accessibility to wearable, science-backed pain management solutions for consumers and healthcare providers.
Keep building. Keep learning. Keep growing with StartupByDoc.